Phase 2 Myasthenia Gravis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 85 years old
- You have been diagnosed with generalized Myasthenia Gravis (a muscle weakness condition) that falls within a moderate to severe range of severity, known as MGFA Class II-IV (confirm with trial site)
- There may be additional requirements set out in the full study protocol (confirm with trial site)
Who may not be able to join:
- You currently have cancer, or have been diagnosed with cancer at any point in the last 5 years
- You are currently pregnant, breastfeeding, or are planning to become pregnant during the study
- There may be additional reasons set out in the full study protocol that could affect eligibility (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 833-606-5975
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To assess the safety and tolerability of aritinercept: Incidence of treatment-emergent adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.